ConductScience.org, home

Paper41005350

Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial.

Hu X and 7 others. J Natl Compr Canc Netw, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial. Papers, record 41005350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41005350

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial.
PubMed
Journal
J Natl Compr Canc Netw
PubMed
Year
2025
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu XXin
2Krukowski RARebecca A
3Stepanski EEdward
4Anderson JNJaneane N
5Vidal GAGregory A
6Torres MAMylin A
7Schwartzberg LSLee S
8Graetz IIlana

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, HormonalMajor topic
Breast NeoplasmsMajor topic
Medication AdherenceMajor topic
Adult
Aged
Female
Humans
Middle Aged
Black or African American
Chemotherapy, Adjuvant
Symptom Burden
White

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA218155NCI NIH HHSUnited StatesR01CA218155PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03592771THRIVE Breast Cancer App StudyDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127459660Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis.J Manag Care Spec Pharm2016https://conductscience.org/library/papers/27459660PubMed
234437611The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.PLoS One2021https://conductscience.org/library/papers/34437611PubMed
324319297Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.J Soc Issues2012https://conductscience.org/library/papers/24319297PubMed
429031778Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.Lancet Oncol2017https://conductscience.org/library/papers/29031778PubMed
535947386Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.JAMA Netw Open2022https://conductscience.org/library/papers/35947386PubMed
629671113Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.Breast Cancer Res Treat2018https://conductscience.org/library/papers/29671113PubMed
736306118Trends in Racial and Ethnic Disparities in Barriers to Timely Medical Care Among Adults in the US, 1999 to 2018.JAMA Health Forum2022https://conductscience.org/library/papers/36306118PubMed
834767562The role of health literacy in cancer care: A mixed studies systematic review.PLoS One2021https://conductscience.org/library/papers/34767562PubMed
910481946Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.Breast Cancer Res Treat1999https://conductscience.org/library/papers/10481946PubMed
1035143040Cancer statistics for African American/Black People 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35143040PubMed
1118180462Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.J Clin Oncol2008https://conductscience.org/library/papers/18180462PubMed
1228922787Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).J Natl Cancer Inst2018https://conductscience.org/library/papers/28922787PubMed
1312586795Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol2003https://conductscience.org/library/papers/12586795PubMed
1429623576Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions.Breast Cancer Res Treat2018https://conductscience.org/library/papers/29623576PubMed
1527893470The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.Am J Clin Oncol2018https://conductscience.org/library/papers/27893470PubMed
1629150730Racial differences in symptom management experiences during breast cancer treatment.Support Care Cancer2018https://conductscience.org/library/papers/29150730PubMed
1729110151Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.Breast Cancer Res Treat2018https://conductscience.org/library/papers/29110151PubMed
1821760482Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy.Cancer Nurs2012https://conductscience.org/library/papers/21760482PubMed
1931037379Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.Support Care Cancer2020https://conductscience.org/library/papers/31037379PubMed
2031039059Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.J Manag Care Spec Pharm2019https://conductscience.org/library/papers/31039059PubMed

See all 60 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42944687GLP-1 RA Prescribing in Patients With Type 2 Diabetes and Cancer.JAMA Netw Open2026https://conductscience.org/library/papers/42944687

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41005350

GET https://conductscience.org/api/papers/v1/41005350/references?page=2